CLINICAL ISSUES IN ANTIBODY DESIGN

被引:64
作者
CHESTER, KA [1 ]
HAWKINS, RE [1 ]
机构
[1] MRC CTR,DEPT ONCOL,CAMBRIDGE CB2 2HQ,ENGLAND
关键词
D O I
10.1016/S0167-7799(00)88968-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antibody genes can now be cloned and expressed in various ways to give new versions of antibodies that possess reduced immunogenicity, improved affinity, altered size, increased avidity and novel effector functions. The task for any clinical application is, first, to define a relevant target, and then to design the optimal antibody-based therapeutic molecule to react with that target. This article reviews these improved antibody-based molecules and examines their role in cancer therapy.
引用
收藏
页码:294 / 300
页数:7
相关论文
共 55 条
[1]  
Bagsgawe K., 1995, TUMOUR TARGETING, V1, P17
[2]   THE 1ST BAGSHAWE LECTURE - TOWARDS GENERATING CYTO-TOXIC AGENTS AT CANCER SITES [J].
BAGSHAWE, KD .
BRITISH JOURNAL OF CANCER, 1989, 60 (03) :275-281
[3]   INTRACELLULAR IMMUNIZATION WITH CYTOSOLIC RECOMBINANT ANTIBODIES [J].
BIOCCA, S ;
PIERANDREIAMALDI, P ;
CAMPIONI, N ;
CATTANEO, A .
BIO-TECHNOLOGY, 1994, 12 (04) :396-399
[4]   ERADICATION OF LARGE SOLID TUMORS IN MICE WITH AN IMMUNOTOXIN DIRECTED AGAINST TUMOR VASCULATURE [J].
BURROWS, FJ ;
THORPE, PE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8996-9000
[5]   PHAGE LIBRARIES FOR GENERATION OF CLINICALLY USEFUL ANTIBODIES [J].
CHESTER, KA ;
BEGENT, RHJ ;
ROBSON, L ;
KEEP, P ;
PEDLEY, RB ;
BODEN, JA ;
BOXER, G ;
GREEN, A ;
WINTER, G ;
COCHET, O ;
HAWKINS, RE .
LANCET, 1994, 343 (8895) :455-456
[6]   PHAGE ANTIBODIES - WILL NEW COLICLONAL ANTIBODIES REPLACE MONOCLONAL-ANTIBODIES [J].
CHISWELL, DJ ;
MCCAFFERTY, J .
TRENDS IN BIOTECHNOLOGY, 1992, 10 (03) :80-84
[7]   TARGETING ENZYMES FOR CANCER-THERAPY - OLD ENZYMES IN NEW ROLES [J].
DEONARAIN, MP ;
EPENETOS, AA .
BRITISH JOURNAL OF CANCER, 1994, 70 (05) :786-794
[8]  
DESHANE J, 1994, GENE THER, V1, P332
[9]   MONOCLONAL ANTIBODY-TARGETED SUPERANTIGENS - A DIFFERENT CLASS OF ANTITUMOR AGENTS [J].
DOHLSTEN, M ;
HEDLUND, G ;
AKERBLOM, E ;
LANDO, PA ;
KALLAND, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9287-9291
[10]   ABLATION OF E2A IN RECOMBINANT ADENOVIRUSES IMPROVES TRANSGENE PERSISTENCE AND DECREASES INFLAMMATORY RESPONSE IN MOUSE-LIVER [J].
ENGELHARDT, JF ;
YE, XH ;
DORANZ, B ;
WILSON, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6196-6200